Table 4.
Comparison between groups: final diagnosis of patients undergone colonoscopy.
| Final diagnosis | Preparation | P value | ||
|---|---|---|---|---|
| Group A | Group B | Group C | ||
| 1. Normal | 44 (44.4%) | 35 (35.4%) | 46 (47.4%) | 0.203 |
| 2. Colon adenoma/cancer | 45 (45.5%) | 48 (48.5%) | 36 (37.1%) | 0.252 |
| 3. Irritable bowel syndrome | 13 (11.0%) | 18 (16.8%) | 11 (9.9%) | 0.351 |
| 4. Colonic diverticula | 9 (7.6%) | 7 (6.5%) | 4 (3.6%) | 0.371 |
| 5. GI hemorrhage | 4 (3.4%) | 6 (5.6%) | 1 (0.9%) | 0.170 |
| 6. Hemorrhoids | 6 (5.1%) | 2 (1.9%) | 5 (4.5%) | 0.350 |
| 7. Colitis | 6 (5.1%) | 4 (3.7%) | 5 (4.5%) | 0.810 |
| 8. Newly diagnosed IBD (UC/CD) | 1 (0.8%) | 1 (0.9%) | 3 (2.7%) | 0.436 |
| 9. Known IBD (UC/CD) | 0 (0.0%) | 1 (0.9%) | 3 (2.7%) | 0.166 |
| 10. Others | 5 (4.2%) | 4 (3.7%) | 6 (5.4%) | 0.801 |
1. Normal: includes small hyperplastic polyps approved by pathology; 10. Others: includes gastrointestinal tract lymphoma, melanosis coli, cholecystitis and pancreatic neoplasm, gastric adenoma, or malignancy. Multiple diagnoses per person were possible. GI: gastrointestinal; IBD: inflammatory bowel disease; UC: ulcerative colitis; CD: Crohn's disease.